Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 7/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26581633 | 0.89 | MCL1 (0.52) | MCL1RIPK1CNR1PTGER4XDH | |
| SCHEMBL20604810 | 0.88 | MCL1 (0.49) | MCL1RIPK1CNR1PTGER4XDH | |
| SCHEMBL30790922 | 0.88 | MCL1 (0.49) | MCL1RIPK1CNR1PTGER4XDH | |
| SCHEMBL23809422 | 0.88 | MCL1 (0.43) | MCL1RIPK1CNR1PTGER4 | |
| SCHEMBL20604962 | 0.82 | MCL1 (0.43) | MCL1RIPK1CNR1PTGER4XDH | |
| SCHEMBL20605746 | 0.78 | MCL1 (0.41) | MCL1PTGER4 | |
| SCHEMBL30790899 | 0.78 | MCL1 (0.41) | MCL1PTGER4 | |
| SCHEMBL23809288 | 0.78 | MCL1 (0.43) | MCL1RIPK1 | |
| SCHEMBL23809509 | 0.77 | MCL1 (0.44) | MCL1PTGER4CNR2 | |
| SCHEMBL26581596 | 0.76 | MCL1 (0.47) | MCL1CNR1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210283138-A1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | VANDERBILT UNIVERSITY | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283138-A1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | MCL1, BCL2L1, BCL9 | MCL1 1/4885RIPK1 560/4885CNR1 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.